This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS, this notice publishes the:
- A decision made by a delegate of the Secretary pursuant to regulations 42ZCZR;
- reasons for that final decision; and
- date of effect of the decision.
Final decision and reasons
- Notice of final decisions - ACMS #37, Joint ACMS-ACCS #30, ACCS #33, March 2022 meeting (pdf,260kb)
- Notice of final decisions - ACMS #37, Joint ACMS-ACCS #30, ACCS #33, March 2022 meeting (docx,240kb)
We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au.
Contents
- 1 Notice of final decisions to amend (or not amend) the current Poisons Standard
- 2 Final decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #37, March 2022)
- 2.1 Final decision in relation to azelastine and fluticasone propionate
- 3 Final decisions on proposed amendments referred to the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS #30, March 2022)
- 3.1 Final decision in relation to cannabis and tetrahydrocannabinols (THC’s)
- 3.2 Final decision in relation to lead
- 3.3 Final decision in relation to meloxicam
- 3.4 Final decision in relation to lidocaine
- 4 Final decisions on proposed amendments referred to the Advisory Committee on Chemicals Scheduling (ACCS #33, March 2022)
- 4.1 Final decision in relation to flumioxazin